반복영역 건너뛰기
지역메뉴 바로가기
주메뉴 바로가기
본문 바로가기

연구정보

[보건] Rohingya Refugee Crisis in Cox’s Bazar District, Bangladesh: Health Sector Bulletin No. 16, Reporting period: July to September 2021

방글라데시 국외연구자료 연구보고서 - OCHA 발간일 : 2021-12-23 등록일 : 2022-01-13 원문링크

The first phase of COVID-19 vaccination has been completed among the Rohingya Refugee targeting the age group of 55 years and above. 36,943 people received the 1st dose of COVID-19 vaccine in 1st round which successfully reached 86% of the target population. 33,386 people received 2nd dose of COVID-19 vaccine in 2nd round which reached 90% of 2nd round target. Overall, 86% of targeted people received at least 1 dose of COVID-19 vaccine whereas 77% people of targeted people completed both doses of COVID-19 vaccination.

In Bangladesh overall, quarter three was characterized by a slight decline in COVID-19 infections. Similarly, a decline in infections was recorded in the Rohingya refugee/Forcibly Displaced Myanmar Nationals (FDMN) camps.

Among the Rohingya refugees, 1,321 (56 percent-female, 44 percent-male) new infections were recorded during the reporting period, compared to 1,349 in the second quarter. The testing rate decreased by 9 percent.

Health Sector partners, at the request of government, currently operate 13 Severe Acute Respiratory Infection Isolation and Treatment Centres (SARI ITCs) in the refugee camps with a Total of 641 active beds by the end of September. In addition, approximately 250 additional standby beds can be activated based on epidemiological indications.

Outpatient Department (OPD) consultations among Rohingya refugees and host communities remained above standards this quarter.

During the reporting period (Jul-Sept 21), the highest facility-based delivery of 71% was registered in September 2021. Month-by-month, utilization has increased at least 3% from the last reporting period likely due to lifting of movement restrictions related to COVID-19.

본 페이지에 등재된 자료는 운영기관(KIEP)EMERiCs의 공식적인 입장을 대변하고 있지 않습니다.

목록